Table 1.
Parameter | Group D (n = 30) |
Group S (n = 30) |
Group DS1 (n = 30) |
Group DS2 (n = 30) |
Group DS3 (n = 30) |
P-value |
---|---|---|---|---|---|---|
Age; y | 36(10) | 37(12) | 36(11) | 38(11) | 37(11) | 0.435 |
BMI; kg/m2 | 23(2) | 22(2) | 22(2) | 21(2) | 24(2) | 0.324 |
ASA status; I/II | 20/10 | 19/11 | 22/8 | 20/10 | 21/9 | 0.267 |
Duration of surgery; min | 83(23) | 87(21) | 80(22) | 85(27) | 81(26) | 0.213 |
NRS score on PACU admission | 5(1) | 6(1) | 5(1) | 6(1) | 6(1) | 0.546 |
Type of surgery(n) | ||||||
Hysterectomy | 15 | 13 | 16 | 15 | 14 | |
Myomectomy | 10 | 12 | 7 | 9 | 11 | 0.132 |
Enucleation of ovarian cyst | 5 | 5 | 6 | 6 | 5 |
Note: Data are expressed as mean (SD) or number.
Abbreviations: BMI, body mass index; NRS, numerical rating scale; Group D, dezocine group; Group S, sufentanil group; Group DS1, ratio of dezocine:sufentanil = 3:1; Group DS2, ratio of dezocine:sufentanil = 1:1; Group DS3, ratio of dezocine:sufentanil = 1:3.